Literature DB >> 1950896

MR imaging of intradural inflammatory diseases of the spine.

B Gero1, G Sze, H Sharif.   

Abstract

Twenty-eight patients with intradural inflammatory disease of the spine were studied in order to characterize the MR imaging findings of infectious and inflammatory conditions. Patients were categorized according to the spinal compartment involved. Among the 12 patients in the intradural extramedullary group, unenhanced scans were either normal or nonspecific while contrast-enhanced scans were helpful in visualizing and localizing the lesion. Nevertheless, contrast-enhanced MR studies were unable to differentiate infection and inflammation from tumor in this compartment. Among 16 patients with intramedullary lesions, four had granulomatous disease and 12 had nongranulomatous disease. The granulomatous lesions resembled tumors and displayed MR characteristics of a focal lesion with large nodular enhancement. The patients with nongranulomatous intramedullary lesions exhibited two subsets of MR findings. In the first subset of nine patients, diffuse cord swelling and high signal were seen on long TR images, combined with either no enhancement or peripheral, diffuse, or speckled enhancement of the spinal cord on contrast-enhanced short TR images. In the second subset of three patients, minimal or no spinal cord swelling was displayed despite the visualization of high signal on long TR scans and nodular enhancement with contrast administration on short TR scans. Both subsets were sufficiently unique that nongranulomatous myelitis could usually be differentiated from spinal cord tumors.

Entities:  

Mesh:

Year:  1991        PMID: 1950896      PMCID: PMC8333521     

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  11 in total

1.  HTLV-I-associated myelopathy: acute progression and atypical MR findings.

Authors:  M Shakudo; Y Inoue; T Tsutada
Journal:  AJNR Am J Neuroradiol       Date:  1999-09       Impact factor: 3.825

2.  Subacute combined degeneration of the spinal cord: MRI detection of preferential involvement of the posterior columns in a child.

Authors:  L J Wolansky; G Goldstein; A Gozo; H J Lee; I Sills; S Chatkupt
Journal:  Pediatr Radiol       Date:  1995

Review 3.  Acute onset intramedullary spinal cord abscess with spinal artery occlusion: a case report and review.

Authors:  Motoyuki Iwasaki; Shunsuke Yano; Takeshi Aoyama; Kazutoshi Hida; Yoshinobu Iwasaki
Journal:  Eur Spine J       Date:  2011-02-10       Impact factor: 3.134

Review 4.  [Inflammatory diseases of the spinal column and the myelon].

Authors:  F J Ahlhelm; J M Lieb; S Ulmer; T Sprenger; C Stippich; J Kelm
Journal:  Radiologe       Date:  2011-09       Impact factor: 0.635

5.  Acute human T-lymphotropic virus type I-associated myelitis: a rare case successfully treated with intravenous pulse methylprednisolone.

Authors:  Reza Boostani; Ali Ghabeli Juibary
Journal:  J Neurovirol       Date:  2014-05-28       Impact factor: 2.643

Review 6.  Tuberculosis of the central nervous system.

Authors:  R K Garg
Journal:  Postgrad Med J       Date:  1999-03       Impact factor: 2.401

7.  Acute infectious disorders of the spinal cord and its roots with gadolinium-DTPA enhancement in magnetic resonance imaging.

Authors:  S Engelter; P Lyrer; E W Radu; A J Steck
Journal:  J Neurol       Date:  1996-02       Impact factor: 4.849

8.  Is extensive cervical laminoplasty an effective treatment for spinal cord sarcoidosis combined with cervical spondylosis?

Authors:  Keisuke Oe; Minoru Doita; Hiroshi Miyamoto; Fumio Kanda; Masahiro Kurosaka; Masatoshi Sumi
Journal:  Eur Spine J       Date:  2009-02-12       Impact factor: 3.134

9.  MRI in intraspinal tuberculosis.

Authors:  R K Gupta; S Gupta; S Kumar; A Kohli; U K Misra; R B Gujral
Journal:  Neuroradiology       Date:  1994       Impact factor: 2.804

Review 10.  Spinal infections.

Authors:  E Turgut Tali; Serap Gültekin
Journal:  Eur Radiol       Date:  2004-12-31       Impact factor: 7.034

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.